🇺🇸 FDA
Patent

US 8512991

Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use

granted A61KA61K38/00A61P

Quick answer

US patent 8512991 (Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, compositions and methods of use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61P, A61P37/04, A61P7/02